# Dx & Vx: Research, South Korea

> Dx & Vx: Dx & Vx is a bio-healthcare company based in South Korea, established in 2001 and previously known as CancerLab Co., Ltd. Based in South Korea.

Source: https://millionrounds.com/startup/dx-vx (Millionrounds; every figure on the page links to its filing or article)

South Korea · [Research startup](https://millionrounds.com/companies)

# Dx & Vx

Dx & Vx is a bio-healthcare company based in South Korea, established in 2001 and previously known as CancerLab Co., Ltd.

Funding reported Last round: Convertible note

Research South Korea

Company summary

- **Founded:** 2001 25 years old
- **Team:** 35 11 to 50 people
- **Funding reported:** 34.8B as listed, currency not stated
- **Last round:** Convertible note Oct 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Dx & Vx has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Dx & Vx

Dx & Vx is a bio-healthcare company based in South Korea, established in 2001 and previously known as CancerLab Co., Ltd.

The company focuses on medical diagnostics, drug development, consumer healthcare, and digital healthcare. In 2022, it rebranded to its current name. The company offers a range of services, including molecular genetic testing, diagnostic services, and health check services. Its product and research portfolio features microbiome-based consumer health supplements, personal care products, and various drugs targeting respiratory diseases, macular degeneration, atopy dermatitis, xerophthalmia, and cancer. Dx & Vx is also involved in developing next-generation therapeutic platforms and has a pipeline addressing infectious diseases, cancer, obesity, and eye diseases. Dx & Vx has engaged in significant collaborations, partnering with over 40 global pharmaceutical and biotechnology companies. Notably, it has a co-development and license agreement for an mRNA cancer vaccine valued at approximately USD 220 million.

## What company datasets say Dx & Vx raised

Funding, as reported

Reported in all **34.8B** in the source's currency

Rounds **2**

Last round **Convertible note**

Last round size **14.9M**

Last round date **Oct 2022**

## The company, in detail

What they build

Known for

biotechnology research

Built with from their website

NAVER OpenSSL Apache Viewport Meta CentOS Mobile Friendly Open Graph Naver Analytics GlobalSign Nginx

+3 more

Apache HTTP Server PHP Google Search Console

- **Sector:** Research
- **Region:** Seoul
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/dx-vx)

## Research in South Korea

Startups like it

- [**Galux** founded 2020 *Raised*](https://millionrounds.com/company/galux)
- [**ExoCoBio** founded 2017 *Raised*](https://millionrounds.com/company/exocobio)
- [**iN Therapeutics** Yongin-si · founded 2020](https://millionrounds.com/startup/in-therapeutics)
- [**Mitoimmune Therapeutics Inc.** Seoul · founded 2018](https://millionrounds.com/startup/mitoimmune-therapeutics-inc)
- [**Cyrus Therapeutics** founded 2019](https://millionrounds.com/startup/cyrus-therapeutics)
- [**G+FLAS Life Sciences, Inc.** Seoul · founded 2014](https://millionrounds.com/startup/g-flas-life-sciences-inc)
- [**Cellmeat** Seoul · founded 2019](https://millionrounds.com/startup/cellmeat)
- [**Bertis Inc** Seongnam-si · founded 2014](https://millionrounds.com/startup/bertis-inc)

## Is this your company?

Add your raise, your deck and your story, and put Dx & Vx in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)